Latest News Archive

Please select Category, Year, and then Month to display items

Episode one - featuring Likeleli Monyamane

01 February 2021 | Story Dr Nitha Ramnath | Photo Supplied

Likeleli Monyamane_web read more — Likeleli Monyamane.

In our first episode of the Voices of the Free State podcast series, Likeleli Monyamane takes us through her journey as a student at the UFS. Founder of Inspire Innovation Business Consultants, Likeleli is a chartered accountant based in Lesotho, with a deep passion for skills development and mentorship. ‘Build people, build the nation’ is the motto that Likeleli subscribes to. Losing her parents at a young age, Likeleli was raised by her grandmother and forged ahead despite the challenges she faced. Commitment to her vision and inspiration from her mum, which left an imprint on her, was what kept Likeleli grounded.

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.

Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021. Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important.

The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them.

Our podcast guest

A chartered accountant by profession, Likeleli Monyamane is founder of Inspire Innovation Business Consultants and Head of Strategy, Projects and Innovation at Alliance Insurance. As a recipient of the Mandela Washington Fellowship, Likeleli attended the Cambridge College in Massachusetts, USA. She was also selected as one of the Top 35-under-35 chartered accountants by the South African Institute of Chartered Accountants.

Stay tuned for episode two to be released on 1 March 2021, featuring Bertus Jacobs, Chief Technology Officer of IoT.nxt.

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za

Listen to the Podcast here:

University of the Free State · Voices from the Free State Podcast - Likeleli Monyamane

News Archive

Researchers receive study grant for research into Congo Fever

2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept